Valuation: Acarix AB

Market Cap 299M 31.38M 27.28M 25.39M 23.31M 44.02M 3B 44.7M 117M 1.49B 118M 115M 5B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 299M 31.38M 27.28M 25.39M 23.31M 44.02M 3B 44.7M 117M 1.49B 118M 115M 5B EV / Sales 2026 *
15.7x
EV / Sales 2027 * 4.31x
Free-Float
83.24%
Yield 2026 *
-
Yield 2027 * -
1 day-16.31%
1 month-24.57%
3 months-27.09%
6 months-36.81%
Current year-28.52%
1 month 0.02
Extreme 0.0218
0.03
Current year 0.02
Extreme 0.0218
0.04
1 year 0.02
Extreme 0.0218
0.04
3 years 0.01
Extreme 0.009
0.07
5 years 0.01
Extreme 0.009
0.07
10 years 0.01
Extreme 0.009
0.07
Manager TitleAgeSince
Chief Executive Officer - 2024-01-31
Chief Executive Officer 62 2018-02-22
Director TitleAgeSince
Director/Board Member 61 2019-12-31
Director/Board Member 52 2024-05-13
Director/Board Member - 2024-05-13
Change 5-day change 1-year change 3-year change Capi.($)
-16.31%-.--% - - 31.38M
-1.89%-1.36%+16.24%-41.91% 15.7B
+4.47%+7.46%+1.25%+106.27% 1.77B
+1.21%+4.49%-27.15%-80.80% 1.14B
-1.73%+2.33%-38.79%+13.42% 980M
+1.29%+7.31%-46.81%-52.67% 655M
+0.93%+7.41%-45.76%-53.34% 543M
+1.08%+2.47%+53.71%-51.95% 472M
-0.81%+1.33%-53.54%-62.03% 374M
-0.81%+5.14%-15.69%-32.94% 368M
Average -1.26%+2.54%-17.39%-28.44% 2.45B
Weighted average by Cap. -0.97%-0.19%+6.00%-30.54%

Financials

2026 *2027 *
Net sales 19.1M 2M 1.74M 1.62M 1.49M 2.81M 191M 2.85M 7.5M 95.17M 7.52M 7.36M 319M 69.5M 7.29M 6.33M 5.9M 5.41M 10.22M 696M 10.38M 27.28M 346M 27.37M 26.77M 1.16B
Net income -28.9M -3.03M -2.63M -2.45M -2.25M -4.25M -289M -4.32M -11.34M -144M -11.38M -11.13M -483M 2.4M 252K 219K 204K 187K 353K 24.02M 358K 942K 11.96M 945K 924K 40.1M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8

Quarterly revenue - Rate of surprise